This inventor holds 1 USPTO granted patent. Top assignee: Phage Biotechnology Corporation. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: Oleg Okunev: Inventor in Antibody Biotechnology
Introduction
Oleg Okunev is an inventor associated with Kyiv, Ukraine, and Phage Biotechnology Corporation. His work includes a patented method for producing single-chain antibodies to human interferon α2b.
Latest Patents
The available patent information lists one patent for Okunev: “Method for Obtaining Single Chain Antibodies to Human Interferon α2b.” The invention describes a bacterial high-expression system for screening large numbers of recombinant clones from combinatorial antibody libraries. It enables screening of approximately 10 clones in a single round, with selected clones available for producing antibodies in microorganism cultures. The disclosure also describes a refolding method for large-scale production of biologically active scFv-6 his proteins from bacterial inclusion bodies. Okunev is credited with 1 patent.
Career Highlights
Okunev’s listed patent work focuses on antibody discovery and production, including efficient library screening and methods for producing biologically active antibody fragments. He is associated with Phage Biotechnology Corporation.
Collaborations
The listed collaborators include Olena Deryabina and Vitaliy A. Kordyum.
Conclusion
Oleg Okunev’s recorded invention addresses practical approaches to screening antibody libraries and producing single-chain antibody proteins, reflecting his connection to biotechnology innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile